Kent Thune's profile photo

Kent Thune

Hilton Head

Finance Writer at etf.com

Kent Thune, CFP®, is a wealth manager, philosopher and writer with decades of experience helping others navigate their investments and find meaning in life.

Articles

  • 2 days ago | etf.com | Kent Thune

    Big pharma stocks, as measured by the VanEck Pharmaceutical ETF (PPH), plunged Monday morning then recovered in afternoon trading as investors reacted to mixed messages about President Donald Trump’s sweeping plan to cut prescription drug prices by as much as 80%. PPH top holdings like Eli Lilly & Co. (LLY) and Johnson & Johnson Inc. (JNJ) fell as much as 4% in early trading.

  • 6 days ago | etf.com | Kent Thune

    - High income combined with a volatility buffer have attracted over $60 billion to these covered call funds. - While both ETFs use similar option-based income strategies, their equity exposures and outcomes differ. Covered call ETFs like the JPMorgan Equity Premium Income ETF (JEPI) and the JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) have soared in popularity as investors search for income strategies in a persistently low-yield environment.

  • 1 week ago | etf.com | Kent Thune

    The Federal Reserve maintained its key interest rate within the 4.25%-4.5% range for the third consecutive meeting on Wednesday, a decision widely anticipated by market observers.  This holding pattern comes even as the central bank acknowledged a heightened level of concern regarding the dual risks of escalating inflation and rising unemployment within the current economic environment.

  • 1 week ago | etf.com | Kent Thune

    - Capital gains on gold are generally taxed at higher rates than traditional investments. - Understanding the tax implications of your gold ETF investments is just as crucial as understanding the underlying asset. Amidst fears of an escalating global trade war and a slowing global economy, gold ETFs have become an increasingly popular way for investors to gain exposure to this precious metal without the complexities of physical ownership.

  • 1 week ago | etf.com | Kent Thune

    This week has presented a challenging landscape for biotech ETF investors and advisors, as exchange-traded funds like the SPDR S&P Biotech ETF (XBI) faced headwinds from a confluence of political and economic factors.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
519
Tweets
366
DMs Open
No
No Tweets found.